Compounds of the formula (I), in which R.sup.1a--R.sup.1e, R.sup.2a, R.sup.2b, R.sup.3 and X have the meanings indicated in claim 1, are inhibitors of tyrosine kinases, in particular TIE-2, and Raf kinases and can be employed, inter alia, for the treatment of tumours. ##STR00001##

 
Web www.patentalert.com

< 17-acetamido-4-azasteroid derivatives as androgen receptor modulators

> HIV protease inhibiting compounds

> Function and regulation of ADAMTS-1

~ 00597